SMTL ID : 6vl5.1

BG505 SOSIP reconstructed from a designed tetrahedral nanoparticle, BG505 SOSIP-T33_dn2

Coordinates
PDB Format
Method
ELECTRON MICROSCOPY
Oligo State
hetero-3-3-mer
Ligands
3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
27 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
36 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Martin, J.T. et al., Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations. NPJ Vaccines (2020)
Release Date
2020-08-12
Peptides
BG505 SOSIP.v5.2(7S) - gp120: ACE
BG505 SOSIP.v5.2(7S) - gp41: BDF
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
C
C
A
E
E
B
D
D
B
F
F

BG505 SOSIP.v5.2(7S) - gp120

Toggle Identical (ACE)

BG505 SOSIP.v5.2(7S) - gp41

Toggle Identical (BDF)

Related Entries With Identical Sequence

7l8s.1